Biblio
“Validation of the Spanish version of the Baylor Profound Mental Status Examination.”, J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.
, “Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1021-8, 2016.
, “A Validation Study of Vascular Cognitive Impairment Genetics Meta-Analysis Findings in an Independent Collaborative Cohort.”, J Alzheimers Dis, vol. 53, no. 3, pp. 981-9, 2016.
, “The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.”, J Alzheimers Dis, vol. 52, no. 2, pp. 539-59, 2016.
, “Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1607-1618, 2016.
, “Vascular Health Indices and Cognitive Domain Function: Singapore Longitudinal Ageing Studies.”, J Alzheimers Dis, vol. 50, no. 1, pp. 27-40, 2016.
, “Vascular Risk Factors and Cognition in Parkinson's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 563-70, 2016.
, “Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.”, J Alzheimers Dis, vol. 50, no. 3, pp. 751-8, 2016.
, “Vitamin D and Memory Decline: Two Population-Based Prospective Studies.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1099-108, 2016.
, “Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.”, J Alzheimers Dis, vol. 53, no. 2, pp. 419-44, 2016.
, “Vitamin D Supplementation Appears to Increase Plasma Aβ40 in Vitamin D Insufficient Older Adults: A Pilot Randomized Controlled Trial.”, J Alzheimers Dis, vol. 52, no. 3, pp. 843-7, 2016.
, “Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.”, J Alzheimers Dis, vol. 49, no. 1, pp. 237-49, 2016.
, “What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?”, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
, “White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.
, “White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study.”, J Alzheimers Dis, vol. 49, no. 3, pp. 863-73, 2016.
, “White Matter Changes are Associated with Ventricular Expansion in Aging, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 329-42, 2016.
, “Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 54, no. 1, pp. 325-35, 2016.
, “Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.”, J Alzheimers Dis, vol. 54, no. 2, pp. 635-43, 2016.
, “The Zebrafish Equivalent of Alzheimer's Disease-Associated PRESENILIN Isoform PS2V Regulates Inflammatory and Other Responses to Hypoxic Stress.”, J Alzheimers Dis, vol. 52, no. 2, pp. 581-608, 2016.
, “Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues.”, J Alzheimers Dis, vol. 54, no. 2, pp. 809-19, 2016.
, “δ Scores are Exportable Across Cultural and Linguistic Boundaries.”, J Alzheimers Dis, vol. 49, no. 2, pp. 561-70, 2016.
, “Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.”, J Alzheimers Dis, 2015.
, “Adipose Tissue Distribution in Patients with Alzheimer's Disease: A Whole Body MRI Case-Control Study.”, J Alzheimers Dis, 2015.
, “Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.”, J Alzheimers Dis, vol. 48, no. 1, pp. 175-87, 2015.
, ,